Prognostic value of homocysteine and vitamin D in patients with ischemic heart disease before aorto-coronary bypass surgery
Diseases of the cardiovascular system is one of the most acute medical and social problems of modern society. Ischemic heart disease (IHD) and cerebral stroke were and remain the leading cause of death and disability. It is established that in the development of IHD and its complications, at present, hyperhomocysteinemia and vitamin D deficiency are considered.
The aim of the study was to study the effect of hyperhomocysteinemia and vitamin D deficiency on the course of coronary heart disease. The study analyzed the data of 65 patients who were divided into two groups, based on the prevalence of atherosclerosis. In all patients with ischemic heart disease, vitamin D deficiency and hyperhomocysteemia were more pronounced in case of multifocal atherosclerosis, which should be taken into account when prescribing medication after myocardial revascularization.
2. The oxidative stress maybe induced by the elevated homocysteine in schizophrenic patients / Dietrich-Muszalska A., Malinowska J., Olas B. et al. // Neurochem. Res. – 2012. – Vol. 37 (5). – P. 1057–62. doi:10.1007/ s11064-012-0707-3.
3. McCully K. S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis // Amer. J. Pathology. – 1969. – Vol. 56. – P. 111–128.
4. Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with is chemic stroke/ WangH., FanD., Zhang H. et al. // Neurol. Res. – 2006. – Vol. 28. – P. 25–30.
5. Role of Vitamin D in Atherosclerosis / Eva Kassi, Christos Adamopoulos, Efthimia K. Basdra et al. // Circulation. – 2013. – Vol. 128. – P. 2517–2531.
6. Total plasma homocysteine and cardiovascular risk profile: the Hordal and Homocysteine Study / Nygard O., Vollset S. E., Refsum H. et al. // JAMA. – 1995. – Vol. 274. – P. 1526–1533. .
7. Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function / Bilsborough W., Green D. J., Mamotte C. D. S. et al. // Atherosclerosis. – 2003. – Vol. 169 (1). – P. 131–138.
8. Role of oxidant stressing end othelial dysfunction produced by experimental hyperhomocysteinemiain humans / Kanani P. M., Sinkey C. A., Browning R. L. et al. // Circulation. – 1999. – Vol. 100 (11). – P. 1161–1168.
9. Oxidative stress and homocysteine in coronary artery disease / Cavalca V., Cighetti G., Bamonti F. et al. // Clin Chem. – 2001. – Vol. 47 (5). – Р. 887–892.
10. Perna A. F. Homocysteine and oxidative stress / A. F. Per-na, D. Ingrosso, N. G. DeSanto // AminoAcids. – Decem-ber 2003. – Vol. 25, Issue 3–4. – Р. 409–417.
11. Bosn J. Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/ composition in young adult population // BasicMed-Sci. – 2015 Feb 8. – Vol. 15 (1). – Р. 67–72. doi: 10.17305/ bjbms.2015.238.